Assignee
CENTAUR PHARMACEUTICALS INC
US·36 granted patents·397 citations·filing 1994–2001
Top patents by PatentIndex Score
36 records- 0193US6486349B1Amide therapeutics and methods for treating inflammatory bowel diseaseCENTAUR PHARMACEUTICALS INC·Filed 2000·Granted Nov 26, 2002·49 cites·21 claims
- 0287US5756548AAcetamidobenzamide compounds for neurodegenerative disordersCENTAUR PHARMACEUTICALS INC·Filed 1997·Granted May 26, 1998·21 cites·8 claims
- 0386US6258852B1Aryl nitrone therapeutics for the treatment of inflammatory bowel diseaseCENTAUR PHARMACEUTICALS INC·Filed 2000·Granted Jul 10, 2001·20 cites·5 claims
- 0486US5659082ANitro- and aminobenzamide compounds for neurodegenerative disordersCENTAUR PHARMACEUTICALS INC·Filed 1995·Granted Aug 19, 1997·29 cites·11 claims
- 0585US6046232Aα-aryl-N-alkylnitrones and pharmaceutical compositions containing the sameCENTAUR PHARMACEUTICALS INC·Filed 1998·Granted Apr 4, 2000·49 cites·51 claims
- 0678US6441032B1Alpha-(4-Ethoxyphenyl)-N-tert-butylnitrone, pharmaceutical compositions and their medical useCENTAUR PHARMACEUTICALS INC·Filed 2000·Granted Aug 27, 2002·7 cites·8 claims
- 0774US6509378B2Acetamidobenzamide compounds for neurodegenerative disordersCENTAUR PHARMACEUTICALS INC·Filed 2001·Granted Jan 21, 2003·4 cites·32 claims
- 0873US6433008B1α-aryl-N-alkylnitrones and pharmaceutical compositions containing the sameCENTAUR PHARMACEUTICALS INC·Filed 2000·Granted Aug 13, 2002·5 cites·17 claims
- 0973US6310092B1Methods for preventing and treating autoimmune and inflammatory disease using thioether furan nitrone compoundsCENTAUR PHARMACEUTICALS INC·Filed 2000·Granted Oct 30, 2001·5 cites·16 claims
- 1070US6545056B1Aryl nitrone therapeutics and methods for treating inflammatory bowel diseaseCENTAUR PHARMACEUTICALS INC·Filed 2000·Granted Apr 8, 2003·5 cites·23 claims
- 1169US6689911B2ProcessCENTAUR PHARMACEUTICALS INC·Filed 2001·Granted Feb 10, 2004·6 cites·8 claims
- 1268US5658953APharmaceutical compositions of acetamidobenzamide compounds for neurodegenerative disordersCENTAUR PHARMACEUTICALS INC·Filed 1995·Granted Aug 19, 1997·9 cites·26 claims
- 1366US6342523B13,4,5-trisubstituted aryl nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammationCENTAUR PHARMACEUTICALS INC·Filed 1999·Granted Jan 29, 2002·23 cites·38 claims
- 1466US5972977AOphthalmic pharmaceutical compositions comprising a nitrone compound and methods for treating ocular inflammation using such compositionsCENTAUR PHARMACEUTICALS INC·Filed 1997·Granted Oct 26, 1999·10 cites·25 claims
- 1562US5955506ABenzamides for neurodegenerative disorder treatmentCENTAUR PHARMACEUTICALS INC·Filed 1996·Granted Sep 21, 1999·6 cites·24 claims
- 1660US6066765AAcetamidobenzamide compounds for neurodegenerative disordersCENTAUR PHARMACEUTICALS INC·Filed 1998·Granted May 23, 2000·4 cites·5 claims
- 1760US5643965AAminobenzamide compounds for the treatment of neurodegenerative disordersCENTAUR PHARMACEUTICALS INC·Filed 1995·Granted Jul 1, 1997·6 cites·8 claims
- 1857US5942507AFuran nitrone compoundsCENTAUR PHARMACEUTICALS INC·Filed 1997·Granted Aug 24, 1999·10 cites·40 claims
- 1955US6197826B1α-(2-hydroxyphenyl) nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammationCENTAUR PHARMACEUTICALS INC·Filed 1999·Granted Mar 6, 2001·11 cites·40 claims
- 2054US6083989AAryl nitrone therapeutics for the treatment of inflammatory bowel diseaseCENTAUR PHARMACEUTICALS INC·Filed 1999·Granted Jul 4, 2000·14 cites·16 claims
- 2154US6077870APharmaceutical compositions of acetamidobenzamide compounds for neurodegenerative disordersCENTAUR PHARMACEUTICALS INC·Filed 1997·Granted Jun 20, 2000·4 cites·20 claims
- 2254US5998469AThioether furan nitrone compoundsCENTAUR PHARMACEUTICALS INC·Filed 1999·Granted Dec 7, 1999·8 cites·31 claims
- 2354US5914350APharmaceutical compositions of nitro- and aminobenzamide compounds for neurodegenerative disordersCENTAUR PHARMACEUTICALS INC·Filed 1997·Granted Jun 22, 1999·4 cites·11 claims
- 2454US5472983ABenzamide-containing pharmaceutical compositionsCENTAUR PHARMACEUTICALS INC·Filed 1994·Granted Dec 5, 1995·18 cites·19 claims
- 2553US6255353B1Inhibition of angiogenesisCENTAUR PHARMACEUTICALS INC·Filed 1999·Granted Jul 3, 2001·11 cites·25 claims
- 2651US6376540B1Furan nitrone compoundsCENTAUR PHARMACEUTICALS INC·Filed 1997·Granted Apr 23, 2002·7 cites·13 claims
- 2751US6140369ABenzamides for neurodegenerative disorder treatmentCENTAUR PHARMACEUTICALS INC·Filed 1999·Granted Oct 31, 2000·3 cites·14 claims
- 2851US6015831AThiophene nitrone compoundsCENTAUR PHARMACEUTICALS INC·Filed 1999·Granted Jan 18, 2000·9 cites·39 claims
- 2949US6051571AMethods for treating medical dysfunctions and diseases using furan nitrone compoundsCENTAUR PHARMACEUTICALS INC·Filed 1999·Granted Apr 18, 2000·6 cites·31 claims
- 3048US5994396AFuransulfonic acid derivatives and pharmaceutical compositions containing the sameCENTAUR PHARMACEUTICALS INC·Filed 1998·Granted Nov 30, 1999·7 cites·65 claims
- 3147US6127408AMethods for preventing and treating autoimmune and inflammatory diseases using thioether furan nitrone compoundsCENTAUR PHARMACEUTICALS INC·Filed 1999·Granted Oct 3, 2000·5 cites·16 claims
- 3246US6271265B1Amide therapeutics for the treatment of inflammatory bowel diseaseCENTAUR PHARMACEUTICALS INC·Filed 1999·Granted Aug 7, 2001·9 cites·1 claims
- 3346US6140356AOpthalmic pharmaceutical compositions comprising a nitrone compound and methods for treating ocular inflammation using such compositionsCENTAUR PHARMACEUTICALS INC·Filed 1999·Granted Oct 31, 2000·6 cites·29 claims
- 3443US6040444AProcess for preparing furan nitrone compoundsCENTAUR PHARMACEUTICALS INC·Filed 1999·Granted Mar 21, 2000·3 cites·16 claims
- 3543US5907061ANitro- and aminobenzamide compounds for neurodegenerative disordersCENTAUR PHARMACEUTICALS INC·Filed 1997·Granted May 25, 1999·2 cites·1 claims
- 3635US6194465B1Benzamide therapeutics for the treatment of inflammatory bowel diseaseCENTAUR PHARMACEUTICALS INC·Filed 1999·Granted Feb 27, 2001·2 cites·22 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →